{"id":"206","presentation":"308 - Feasibility and Patient Perceptions of Tele-Videoconferencing Visits for LVAD Patients (TeleLVAD Study)","session":"SESSION 77 - ORAL: Optimal Drug Therapy and Monitoring of MCS Patients","filename":"Vidula_TeleLVAD_ISHLT_4_29.pptx","speaker":"H. Vidula<small>, Rochester, NY, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt40th\/206\/jpg\/vidula_telelvad_ishlt_4_29\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6671\/session_token\/947ca59333941ff752cb064d49d4047d","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]